SATT NORD
- Company typePrivate
- Founded2012
- HeadquartersLille, France
- Headcount101–250
- GTM typeB2B
- OfferingServices
SATT NORD firmographics
Firmographics- Name
- SATT NORD
- Legal name
- SATT Nord
- Website
- https://sattnord.fr
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
SATT NORD industry classification
Industry- Product category
- Technology Transfer Services
- NAICS
- Scientific Research and Development Services (5417), Management Consulting Services (54161), Research and Development in the Social Sciences and Humanities (541720)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
- akta.pro primary industry
- Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)
Keywords
Where SATT NORD is headquartered
LocationHeadquarters
- HQ city
- Lille
- HQ country
- France
- HQ region
- Europe
Offices3 records
Markets served
SATT NORD business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Technology Licensing: SATT Nord generates revenue through licensing agreements with companies for technologies developed from public research. They negotiate and manage license contracts, collecting fees and royalties from licensees.
- Startup Equity: SATT Nord creates spin-off companies from research projects and retains equity stakes, generating returns when startups succeed or raise subsequent funding rounds.
- Technology Maturation Funding: SATT Nord invests in technology maturation projects, bearing the financial and technological risk, with returns realized upon successful transfer or licensing.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
SATT NORD product offering
Product offeringCore offering
SATT Nord is a publicly-funded Technology Transfer Acceleration Company (Société d'Accélération du Transfert de Technologies) that bridges French public research institutions and private companies. Its services span identifying research opportunities, protecting intellectual property (97+ patents and software registrations), funding and managing technology maturation projects that bear both technical and financial risk, and commercializing outcomes through licensing agreements or spin-off startup creation. Headquartered in Lille with regional offices in Reims and Amiens, it serves the Hauts-de-France and Champagne-Ardenne territories through a team of expert domain interlocutors.
Product overview
SATT Nord is a Technology Transfer Acceleration Company (Société d'Accélération du Transfert de Technologies) that operates as a service-oriented organization rather than a single software product. Its portfolio consists of core services including Technology Maturation Programs, Intellectual Property Protection, Licensing Services, and Startup Creation Support, complemented by the Tech-365 marketplace platform. The organization also supports and has spin-off relationships with multiple deeptech companies including Aurora (cold plasma sterilization), Apmonia Therapeutics (cancer immunotherapy), InBrain Pharma (Parkinson's treatment via DIVE technology), and Invenis Biotherapies (HPPL biotherapy for neurodegenerative diseases). Additional offerings include Calls for Projects (AMI/AAP) across strategic sectors and initiatives like GRECO EXPER for AI-assisted medical experimentation and the Innover en Nord-Est regional innovation program.
Differentiator
Problem solved
Functional benefit
Products and services
- Technology Maturation Programs Funding and project management to mature research results into technologies ready for transfer to industry. SATT Nord bears the technical and financial risk during the maturation phase, covering scientific development, IP protection, and preparation for market access. Customer is public research researchers and institutions; end outcome is a transferred technology via license or startup.
- Intellectual Property Protection Services End-to-end management of patent filings and software registrations to protect inventions emerging from public research. Service covers prior-art analysis, patent drafting, filing, prosecution, and portfolio maintenance before licensing or transfer. Customer is public research researchers and institutions seeking to valorize inventions.
- Licensing Services Negotiation and management of technology licensing agreements with existing companies (or sublicensing to startups) to commercialize technologies developed from public research. Includes drafting exclusive or non-exclusive license contracts, collecting fees and royalties, and monitoring licensee performance. Customer is private companies seeking innovation pipeline access.
- Startup Creation Support Full accompaniment from technology maturation through company formation for deep-tech spin-offs emerging from research. SATT Nord retains an equity stake in the resulting startup, recruits the CEO, and connects the company with investors and incubators. Customer is researchers seeking startup creation as their commercialization pathway and the resulting spin-off companies.
- Tech-365 Marketplace Platform Marketplace platform operated through the SATT Network that opens up access to licensable technologies from French public research to companies. Includes SATT Nord's portfolio within the broader national SATT Network catalog of available technologies.
- Calls for Projects (AMI/AAP) Targeted calls for expressions of interest and project proposals in specific domains that SATT Nord launches and manages to identify and fund innovative research projects. Mechanism through which researchers access maturation funding in prioritized strategic sectors.
Quantifiable outcome
- 17 technologies transferred to companies in 4 years of operation (by 2016)
- +3 more outcomes
Companies that use SATT NORD
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles3 records
SATT NORD technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
SATT NORD partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- CHU Amiens-PicardiecoreCHU Amiens-Picardie leads the GRECO EXPER consortium (Tiers-Lieu d'Expérimentation) for experimental medicine in digital and AI. SATT Nord is part of this consortium along with UPJV, MipihSIB, innov'a, and Compagnie des Tiers-Lieux.
- SATT SayenscoreSATT Sayens, Conectus, and SATT Nord launched joint 'Innover en Nord-Est' program (2022) as part of SATT Acceleration Project. Focuses on boosting innovation and impact of breakthrough technologies from public research, targeting the north-east of France.
- IRT RaileniumcorePartnership convention signed with IRT Railenium (railway technology research institute) and i-Trans Competitiveness Cluster to strengthen valorization of research projects and encourage technology transfer in the transport sector.
- SATT Grand EstcorePartnership between SATT Grand Est, Conectus Alsace, and SATT Nord to optimize complementarity of skills and actions in the Grand Est region. Aims to simplify access for companies, mutualize field actions, and share best practices following the formation of the Grand Est region.
- Aurora SterilisationcoreSATT Nord facilitated discussions between Aurora, URCA, and CRITT-MDTS for cold plasma sterilization technology development. Negotiated sublicense agreement with Aurora and manages ongoing IP matters.
- BioversyscoreSwiss biotech company Bioversys established subsidiary in Lille (2018) to conduct antibiotic R&D in collaboration with Institut Pasteur de Lille, INSERM, CNRS, University of Lille, and SATT Nord. Collaboration started in 2013 on tuberculosis research.
- EuraTechnologiescorePartnership with EuraTechnologies to encourage and accelerate support for Deep Tech projects, providing startups access to incubator resources and SATT Nord technology transfer services.
- EuraTechnologies (Let's Grow Deeptech Consortium)coreThe 'Let's grow deeptech' consortium, including SATT Nord, won the PIA 3 program 'Integration of SATTs, incubators, and accelerators' operated by Bpifrance.
- CETIMminorCETIM and SATT Network joint call for projects TILT (2nd edition) for technology transfer to mechanical engineering industry, targeting SMEs in the sector.
- ENSAITminorConvention of partnership signed between SATT Nord and ENSAIT (Ecole Nationale Supérieure des Arts et Industries Textiles) for collaborative projects.
- EDIH GreenPowerIT Hauts-de-FranceminorSATT Nord is partner of EDIH GreenPowerIT (European Digital Innovation Hub) for digital transformation support in Hauts-de-France.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
SATT NORD competitors and assessment
Company assessmentBroad incumbents
- CEA Tech: The CEA's tech transfer arm, operating a much larger R&D platform and broader industry-facing portfolio. CEA Tech is a broader incumbent in French public-research valorization, with overlapping capabilities in deeptech licensing and spin-off creation, but at national scale.
Direct peers
- SATT Ouest Valorisation: SATT covering western France with the same SATT Network model. Direct peer on technology maturation, IP protection, and startup creation services offered to public researchers and companies.
- SATT Sud-Est: SATT serving the PACA and Corsica regions with the same SATT Network technology transfer model. Directly comparable in service offering, KPI structure, and PIA/France 2030 funding logic.
- SATT Linksium: SATT covering the Grenoble-Alpes region with a strong deeptech focus. SATT Linksium operates the same technology maturation, IP protection, and licensing model, and competes with SATT Nord for SATT Network benchmarks, I-Lab wins, and downstream deeptech investor mindshare.
- SATT Paris-Saclay: One of the largest French SATTs, operating the same technology transfer acceleration model around the Paris-Saclay research cluster. It is a direct peer in the SATT Network, with the same funding model, same KPIs (maturation, licensing, spin-offs), and overlap in target research domains.
- SATT AxLR: SATT serving Languedoc-Roussillon, operating the same maturation-funding-plus-licensing model within the national SATT Network. Directly comparable in target customer (public researchers), value proposition, and revenue model.
- SATT Erganeo: SATT serving Île-de-France with the same public-private tech transfer model. SATT Erganeo and SATT Nord share the same SATT Network governance, KPIs, and revenue model, although Erganeo covers the largest concentration of French public research labs.
- SATT Sayens: SATT Sayens is a sister SATT covering Grand Est, formed from the merger of SATT Grand Est and Conectus Alsace. SATT Nord and SATT Sayens are joint partners in the 'Innover en Nord-Est' program, operate the same public-funded tech transfer model, and compete for the same national SATT Network projects and benchmarks.
- SATT Toulouse Tech Transfer: SATT serving the Midi-Pyrénées region, with the same public research valorization mandate. SATT Toulouse Tech Transfer is a directly comparable organization in SATT Network benchmarks and operates a similar deeptech-focused spin-off and licensing pipeline.
Emerging players
- INSERM Transfert: INSERM's tech transfer subsidiary, focused on health and biotech research valorization. It is a thematic specialist in the same broader public-research-tech-transfer space as SATT Nord, with significant overlap in SATT Nord's HPPL, TAX2, DIVE, and H-Immune biotech assets.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
SATT NORD social profiles
Digital presenceSATT NORD compliance and trust
Trust signalCompliance1 record
SATT NORD financial estimates
Financial estimateRevenue estimate
Valuation estimate
SATT NORD leadership team
Management profileNumber of profiles
Profiles3 records
SATT NORD funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SATT NORD M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SATT NORD
What does SATT NORD do?
SATT Nord is a publicly-funded Technology Transfer Acceleration Company (Société d'Accélération du Transfert de Technologies) that bridges French public research institutions and private companies. Its services span identifying research opportunities, protecting intellectual property (97+ patents and software registrations), funding and managing technology maturation projects that bear both technical and financial risk, and commercializing outcomes through licensing agreements or spin-off startup creation. Headquartered in Lille with regional offices in Reims and Amiens, it serves the Hauts-de-France and Champagne-Ardenne territories through a team of expert domain interlocutors.
Is SATT NORD a public or private company?
SATT NORD is a private company. It is classified as state government owned and is currently operating.
When was SATT NORD founded?
SATT NORD was founded in 2012. It employs 101 to 250 people.
Where is SATT NORD based?
SATT NORD is headquartered in Lille, France, in the Europe region.
How does SATT NORD make money?
Three revenue lines are on record. Technology Licensing is the primary driver. The others are startup Equity and technology Maturation Funding.
Who are SATT NORD's main competitors?
CEA Tech is listed as a broad incumbent. Direct peers are SATT Ouest Valorisation, SATT Sud-Est, SATT Linksium, SATT Paris-Saclay, SATT AxLR, SATT Erganeo, SATT Sayens and SATT Toulouse Tech Transfer. INSERM Transfert is listed as an emerging player.
Does SATT NORD have an API?
No public API is recorded for SATT NORD.
What industry is SATT NORD in?
SATT NORD's product category is Technology Transfer Services. Its primary akta.pro industry code is HLAJAOAM, Global Health Research, Clinical Trials & Product Development Partnerships (PDPs). Its NAICS code is 5417 and its SIC code is 8731.